NCT06795932

Brief Summary

The goal of this randomized controlled trial is to compare the integrity of somatosensory processing with transcranial magnetique stimulation (TMS) and corticospinal excitability of the affected shoulder in individuals with adhesive capsulitis versus healthy controls. The secondary objective is to compare the clinical and neurophysiological effects of an intervention using tendon vibration (VIB) to induced kinesthetic illusions. This will involve comparing two groups: one receiving a real intervention versus a placebo intervention protocol, both coupled with standardized exercises in individuals with capsulitis. The hypotheses are that the proprioceptive processing and corticospinal excitability are impaired in the presence of capsulitis, and that the VIB + exercises intervention will result in greater improvements than the placebo VIB + exercises. To goal is to establish the first empirical foundations for understanding adhesive capsulitis, using cutting-edge neurophysiological investigation technologies. TMS will be used to explore the presence of maladaptive plasticity in motor networks by assessing the excitability and integrity of the primary motor cortex (M1) and the corticospinal tract. Recruitement: 30 healthy participants and 30 participants with a diagnosis of adhesive capsulitis will undergo 2 baselines assesments, 6 interventions with tendon vibration and 2 follow-up evaluation. Participants will be age- and sex-matched. Baseline and follw-up include:

  • Questionnaires : SPADI, QuickDASH, French version of the Mcgill Pain Questionnaire;
  • Active and passive range of motion;
  • Ultrasound for diagnosing capsulitis. Comparison parameters:
  • active motor threshold (aMT)
  • Motor evoked potential (MEP) latency and amplitude
  • Standardized kinesthetic illusion procedure (SKIP) : direction of illusion, clearness, amplitude/speed. Interventions :
  • 2 baselines including all questionnaires, ultrasound, active and passive range of motion, TMS procedure and SKIP;
  • 2 VIB interventions per week, for 3 weeks
  • Real VIB : 80Hz of vibration to induce kinesthetic illusions,
  • Placebo VIB : 40Hz of vibration that does not induce kinesthetic illusions
  • 2 follow-up including all questionnaires, ultrasound, active and passive range of motion, TMS procedure and SKIP.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Oct 2024Apr 2027

Study Start

First participant enrolled

October 17, 2024

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

November 14, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 28, 2025

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

January 28, 2025

Status Verified

November 1, 2024

Enrollment Period

2.5 years

First QC Date

November 14, 2024

Last Update Submit

January 27, 2025

Conditions

Keywords

Adhesive CapsulitisFrozen shoulderTendon VibrationTranscranial Magnetique StimulationProprioceptionKinesthetic illusions

Outcome Measures

Primary Outcomes (8)

  • Shoulder Pain And Disability Index

    SPADI : Shoulder Pain And Disability Index Thirteen questions to quantify the level of difficulty, ranging from 0 to 10, based on pain and disability. Five questions assess pain (0 = no pain, 10= worst pain imaginable) and eight questions assess the level of difficulty in performing different tasks (0= no difficulty, 10=too difficult, need help).

    at baseline 1 and follow-up 1 : 2 months

  • Quick Disability of the Hand, Arm and Shoulder

    QuickDASH : Quick Disability of the Hand, Arm and Shoulder Allowing the calculation of a percentage ratio from 14 questions, using a visual analogue scale from 1 (no difficulty) to 5 (incapacity), on the effects of pain on daily life activities, work, and sports, in addition to associated symptoms such as paresthesia and sleep disturbances.

    at baseline 1 and follow-up 1: 2 months

  • Questionnaire St-Antoine

    French version of McGill Pain Questionnaire. Subjectively assess the pain level with 16 questions on a scale from 0 (none) to 4 (extremely severe).

    at baseline 1 and follow-up 1: 2 months

  • Range of motion

    Measuring the active and passive range of motion with a goniometer.

    at baseline 1 and follow-up 1: 2 months

  • Standardized Kinesthetic Illusion Procedure

    Using the SKIP to evaluate: * Clarity: 0 = no illusion, 1 = vague, 2 = moderately clear, 3 = perfectly clear * Direction: using words * Speed/amplitude of illusion: using a visual analogue scale where participants mark a point on the line to represent the speed/amplitude (ranging between very slow/small to very fast/high)

    at baseline 1/2 and follow-up 1/2 : 2 months (+/- 2 weeks)

  • Active motor threshold

    The active motor threshold represents the intensity of stimulation (%) required to elicit measurable motor evoked potentials.

    at baseline 1-2 and follow-up 1-2: 2 months (+/- 2 weeks)

  • Amplitude of motor evoked potential

    The measurement of the motor evoked potential amplitude (peak-to-peak) It corresponds to the amount of neurons stimulated at the central et peripheral levels, expressed in microvolts.

    at baseline 1-2 and follow-up 1-2: 2 months (+/- 2 weeks)

  • Latency of motor evoked potential

    The measurement of the motor evoked potential latency in miliseconds. It represent the conduction time from the application of the stimuli over the cortex to the target muscle.

    at baseline 1-2 and follow-up 1-2: 2 months (+/- 2 weeks)

Secondary Outcomes (4)

  • Sociodemographic - age

    at baseline 1 : 1 day

  • Sociodemographic - Sex

    at baseline 1: 1 day

  • Sociodemographic - Weight

    at baseline 1: 1 day

  • Sociodemographic - Height

    at baseline 1: 1 day

Study Arms (2)

Tendon vibration and standardized exercise protocol

EXPERIMENTAL

Six interventions inducing kinesthetic illusions (20 minutes, 1 illusion/minute). Two interventions per week, for three weeks. Accompanied by a daily exercise protocol.

Device: Tendon VibrationOther: Exercices

Tendon vibration without kinesthetic illusion and standardized exercise protocol

SHAM COMPARATOR

Six interventions not inducing kinesthetic illusions (20 minutes) Two interventions per week, for three weeks. Accompanied by a daily exercise protocol.

Other: ExercicesDevice: Tendon vibration

Interventions

Vibration can create kinesthetic illusions when applied at some modalities. The vibration will be put at 80 Hz and 1 mm of amplitude for 10 seconds to create 1 illusion/minute, during 20 minutes. Two interventions per week, for three weeks. Total : 6 interventions

Tendon vibration and standardized exercise protocol

Standardized exercise protocol, performed daily for 3 weeks, with a diary.

Tendon vibration and standardized exercise protocolTendon vibration without kinesthetic illusion and standardized exercise protocol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old and over
  • Good general health
  • Adhesive capsulitis (experimental group) or
  • No shoulder pain (placebo group)

You may not qualify if:

  • Cognitive disorders;
  • Any neurological disease/injury affecting the upper limbs;
  • History or diagnosis of muscle, tendon, or capsular tear;
  • Shoulder surgery/prosthesis;
  • Pregnant woman;
  • Presence of metal in the skull or jaw;
  • History of epilepsy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lab BioNR - UQAC

Saguenay, Quebec, G7H 2B1, Canada

RECRUITING

MeSH Terms

Conditions

BursitisIllusions

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Émilie Bouchard, M.Sc. PhD candidate

CONTACT

Louis-David Beaulieu, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Double blinded randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2024

First Posted

January 28, 2025

Study Start

October 17, 2024

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

January 28, 2025

Record last verified: 2024-11

Locations